NCT07065773 Phase 2 Active not recruiting
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis Study sponsor: Vanda Pharmaceuticals
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2026-09 Estimated
Enrollment · participants 50 Estimated
Source updated 2026-02-04 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-02-04 · 2 fields changed
Primary completion date changed
Recruitment status changed
+ After Active not recruiting
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology